ANPEP and early-onset autosomal dominant Alzheimer disease: More generally, anti-inflammatory actions of ApN in CNS could constitute a means of combating various mental disorders and brain diseases associated with deleterious chronic inflammation or exacerbated inflammatory response, such as depression, anxiety, schizophrenia, stroke, multiple sclerosis, Parkinson's disease, and Alzheimer's disease.